US Broker Ratings

Kestra Medical Technologies (KMTS): A Compelling Growth Play with 7.66% Upside Potential

Investors seeking opportunities in the healthcare sector should pay close attention to Kestra Medical Technologies, Ltd. (KMTS), a company making significant strides in the medical instruments and supplies industry. With..

Vericel Corporation (VCEL): Investor Outlook on Strong Growth and 50% Upside Potential

As Vericel Corporation (NASDAQ: VCEL) continues to carve out its niche in the healthcare sector, the biotechnology firm presents an intriguing investment opportunity, particularly for those interested in the burgeoning..

Addus HomeCare Corporation (ADUS) Investor Outlook: Analyzing the 19.46% Potential Upside

Addus HomeCare Corporation (NASDAQ: ADUS) stands out in the healthcare sector, particularly in the medical care facilities industry, where it operates as a pivotal provider of personal care services. With..

Teladoc Health, Inc. (TDOC) Investor Outlook: Exploring a 30% Upside Potential Amidst Healthcare Innovation

Teladoc Health, Inc. (NYSE: TDOC), a pioneer in virtual healthcare services, offers investors a compelling case for potential upside amidst the evolving landscape of digital health. As a leading player..

AtriCure, Inc. (ATRC) Stock Analysis: Growth Potential in the Surgical Ablation Market

AtriCure, Inc. (NASDAQ: ATRC) stands out in the healthcare sector as a key player in the medical instruments and supplies industry, with a primary focus on devices for surgical ablation..

Pediatrix Medical Group, Inc. (MD) Stock Analysis: Navigating Growth in Healthcare with a 1.56% Upside Potential

Pediatrix Medical Group, Inc. (MD) represents a pivotal player in the healthcare sector, specifically within the medical care facilities industry in the United States. As a provider of specialized newborn,..

Edgewise Therapeutics, Inc. (EWTX)

⚠️ No article content returned.

..

Alphatec Holdings, Inc. (ATEC) Stock Analysis: Exploring a 57% Potential Upside with Robust Analyst Ratings

Alphatec Holdings, Inc. (NASDAQ: ATEC), a leading player in the medical devices industry, particularly in spinal surgery technologies, presents an intriguing investment opportunity. With a current market capitalization of $1.55..

HUTCHMED (China) Limited (HCM) Stock Analysis: Unlocking a Potential 55.74% Upside with Strong Buy Ratings

HUTCHMED (China) Limited (NASDAQ: HCM), a prominent player in the healthcare sector, is crafting a compelling narrative for investors with its robust pipeline of targeted therapeutics and immunotherapies aimed at..

Mesoblast Limited (MESO): Unpacking the 155% Upside Potential in Regenerative Medicine

Mesoblast Limited (NASDAQ: MESO), an Australian biotechnology company, stands as a significant player in the healthcare sector with its pioneering work in regenerative medicine. With a market capitalization of $1.88..

National HealthCare Corporation (NHC) Stock Analysis: Navigating the Healthcare Giant’s Performance Metrics

National HealthCare Corporation (NYSE: NHC), a key player in the healthcare sector, operates within the medical care facilities industry, providing a wide range of services across the United States. With..

Harmony Biosciences Holdings, Inc. (HRMY): Investor Outlook on a Biotech with 18% Upside Potential

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY), operating in the dynamic and ever-evolving biotechnology sector, has carved a niche for itself by focusing on therapies for rare neurological diseases. Headquartered in..

LivaNova PLC (LIVN) Stock Analysis: Exploring a 15.4% Potential Upside in Medical Devices

Investors seeking opportunities in the healthcare sector might find LivaNova PLC (NASDAQ: LIVN) an intriguing prospect, particularly considering the company’s projected 15.4% potential upside. As a key player in the..

Kiniksa Pharmaceuticals (KNSA): Investor Outlook with 28.78% Potential Upside

Kiniksa Pharmaceuticals International, plc (NASDAQ: KNSA) stands out in the healthcare sector, particularly within the drug manufacturers – specialty & generic industry, as a company to watch closely. With a..

Recursion Pharmaceuticals (RXRX) Stock Analysis: Exploring a 95% Potential Upside in Biotech Innovation

Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) stands at the intersection of cutting-edge biotechnology and industrial-scale drug discovery, presenting a unique proposition for investors navigating the dynamic healthcare sector. With a market..

Ardent Health, Inc. (ARDT) Investor Outlook: Navigating the Potential 20.98% Upside

Ardent Health, Inc. (ARDT), a prominent player in the healthcare sector, specifically within the medical care facilities industry, offers its services across the United States. With a market capitalization of..

Organon & Co. (OGN) Stock Analysis: Navigating Challenges with a Strong Return on Equity

Organon & Co. (NYSE: OGN), a prominent player in the healthcare sector, focuses on women’s health solutions and a diverse range of prescription therapies. With a market capitalization of $3.61..

GRAIL, Inc. (GRAL) Investor Outlook: Navigating a 25.70% Revenue Growth in the Healthcare Sector

GRAIL, Inc. (NASDAQ: GRAL), a pioneering force in the healthcare sector, is making notable strides with its innovative approach to early cancer detection. As a commercial-stage company, GRAIL specializes in..

CONMED Corporation (CNMD) Stock Analysis: Navigating Potential in Medical Devices Amid Market Challenges

CONMED Corporation (NASDAQ: CNMD), a notable player in the healthcare sector specializing in medical devices, presents a compelling case for investors, even amidst a challenging market environment. With a market..

ARS Pharmaceuticals, Inc. (SPRY): An Investor Outlook on Potential 444.79% Upside

Investors in ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) have been keeping a close eye on this innovative biopharmaceutical company, which is making significant strides in the healthcare sector. With a focus..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds